These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35328329)

  • 41. Discovery of a Novel HIV-1 Integrase/p75 Interacting Inhibitor by Docking Screening, Biochemical Assay, and in Vitro Studies.
    Wang Y; Lin HQ; Wang P; Hu JS; Ip TM; Yang LM; Zheng YT; Chi-Cheong Wan D
    J Chem Inf Model; 2017 Sep; 57(9):2336-2343. PubMed ID: 28837332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Skp2 regulates DNA damage repair and apoptosis via interaction with Ku70.
    Jia J; Yan D; Wang Y; Liu M; Jia Z; Luo L; Ren J; Fang J; Yuan H; Zhao Y; Song Y; He Y; Wang X
    Exp Cell Res; 2020 Dec; 397(1):112335. PubMed ID: 33132134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication.
    Christ F; Voet A; Marchand A; Nicolet S; Desimmie BA; Marchand D; Bardiot D; Van der Veken NJ; Van Remoortel B; Strelkov SV; De Maeyer M; Chaltin P; Debyser Z
    Nat Chem Biol; 2010 Jun; 6(6):442-8. PubMed ID: 20473303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insight into the inhibitory mechanism and binding mode between D77 and HIV-1 integrase by molecular modeling methods.
    Li P; Tan JJ; Liu M; Zhang XY; Chen WZ; Wang CX
    J Biomol Struct Dyn; 2011 Oct; 29(2):311-23. PubMed ID: 21875151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Addition of E138K to R263K in HIV integrase increases resistance to dolutegravir, but fails to restore activity of the HIV integrase enzyme and viral replication capacity.
    Mesplède T; Osman N; Wares M; Quashie PK; Hassounah S; Anstett K; Han Y; Singhroy DN; Wainberg MA
    J Antimicrob Chemother; 2014 Oct; 69(10):2733-40. PubMed ID: 24917583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies.
    Ma XH; Zhang XY; Tan JJ; Chen WZ; Wang CX
    Acta Pharmacol Sin; 2004 Jul; 25(7):950-8. PubMed ID: 15210071
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain.
    Patel D; Antwi J; Koneru PC; Serrao E; Forli S; Kessl JJ; Feng L; Deng N; Levy RM; Fuchs JR; Olson AJ; Engelman AN; Bauman JD; Kvaratskhelia M; Arnold E
    J Biol Chem; 2016 Nov; 291(45):23569-23577. PubMed ID: 27645997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Noncovalent SUMO-interaction motifs in HIV integrase play important roles in SUMOylation, cofactor binding, and virus replication.
    Zheng Y; Jayappa KD; Ao Z; Qiu X; Su RC; Yao X
    Virol J; 2019 Apr; 16(1):42. PubMed ID: 30940169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kuwanon-L as a New Allosteric HIV-1 Integrase Inhibitor: Molecular Modeling and Biological Evaluation.
    Esposito F; Tintori C; Martini R; Christ F; Debyser Z; Ferrarese R; Cabiddu G; Corona A; Ceresola ER; Calcaterra A; Iovine V; Botta B; Clementi M; Canducci F; Botta M; Tramontano E
    Chembiochem; 2015 Nov; 16(17):2507-12. PubMed ID: 26360521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors.
    Kuo CL; Assefa H; Kamath S; Brzozowski Z; Slawinski J; Saczewski F; Buolamwini JK; Neamati N
    J Med Chem; 2004 Jan; 47(2):385-99. PubMed ID: 14711310
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Binding mode prediction of strand transfer HIV-1 integrase inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 integrase.
    Barreca ML; De Luca L; Iraci N; Chimirri A
    J Med Chem; 2006 Jun; 49(13):3994-7. PubMed ID: 16789757
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization and structural analysis of HIV-1 integrase conservation.
    Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
    AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, biological evaluation and molecular docking of calix[4]arene-based β-diketo derivatives as HIV-1 integrase inhibitors.
    Luo Z; Zhao Y; Ma C; Li Z; Xu X; Hu L; Huang N; He H
    Arch Pharm (Weinheim); 2015 Mar; 348(3):206-13. PubMed ID: 25682937
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Defining the minimal domain of Ku80 for interaction with Ku70.
    Osipovich O; Durum SK; Muegge K
    J Biol Chem; 1997 Oct; 272(43):27259-65. PubMed ID: 9341172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In search of second-generation HIV integrase inhibitors: targeting integration beyond strand transfer.
    Voet AR; Maeyer MD; Debyser Z; Christ F
    Future Med Chem; 2009 Oct; 1(7):1259-74. PubMed ID: 21426102
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural Comparison of Diverse HIV-1 Subtypes using Molecular Modelling and Docking Analyses of Integrase Inhibitors.
    Isaacs D; Mikasi SG; Obasa AE; Ikomey GM; Shityakov S; Cloete R; Jacobs GB
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32858802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Notable difference in anti-HIV activity of integrase inhibitors as a consequence of geometric and enantiomeric configurations.
    Okello M; Mishra S; Nishonov M; Nair V
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4112-6. PubMed ID: 23746474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain.
    Molteni V; Greenwald J; Rhodes D; Hwang Y; Kwiatkowski W; Bushman FD; Siegel JS; Choe S
    Acta Crystallogr D Biol Crystallogr; 2001 Apr; 57(Pt 4):536-44. PubMed ID: 11264582
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
    Czyz A; Stillmock KA; Hazuda DJ; Reznikoff WS
    Biochemistry; 2007 Sep; 46(38):10776-89. PubMed ID: 17725323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of HIV-1 integrase/viral DNA interactions in the catalytic domain by fast molecular docking.
    Adesokan AA; Roberts VA; Lee KW; Lins RD; Briggs JM
    J Med Chem; 2004 Feb; 47(4):821-8. PubMed ID: 14761184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.